Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study Collecting Real-world Data on Patients With Chronic Kidney Disease to Assess: Early Treatment Experience, Treatment Patterns, Treatment Effectiveness, Patient Outcomes and Patient Quality of Life Through Prospective and Retrospective Data Capture

NCT04034992 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04034992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04034992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study Collecting Real-world Data on Patients With Chronic Kidney Disease to Assess: Early Treatment Experience, Treatment Patterns, Treatment Effectiveness, Patient Outcomes and Patient Quality of Life Through Prospective and Retrospective Data Capture
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 11, 2019
Completion date
June 30, 2023
Enrollment
1,052 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease